H D Humes
Professor of Internal Medicine
[email protected]

Available to mentor
H D Humes
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Center for Integrative Research in Critical Care
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    Recent Publications See All Publications
    • Journal Article
      Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states.
      Westover AJ, Humes HD, Pino CJ. Sci Rep, 2024 Jun 3; 14 (1): 12747 DOI:10.1038/s41598-024-63121-9
      PMID: 38830924
    • Journal Article
      Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions.
      Iyer SPN, Pino CJ, Yessayan LT, Goldstein SL, Weir MR, Westover AJ, Catanzaro DA, Chung KK, Humes HD. Transplant Direct, 2024 Jun; 10 (6): e1627 DOI:10.1097/TXD.0000000000001627
      PMID: 38769980
    • Journal Article
      Selective Cytopheretic Device Use in Continuous Kidney Replacement Therapy in Children: A Cohort Study With a Historical Comparator.
      Goldstein SL, Ollberding NJ, Askenazi DJ, Basu RK, Selewski DT, Krallman KA, Yessayan L, Humes HD. Kidney Med, 2024 Apr; 6 (4): 100792 DOI:10.1016/j.xkme.2024.100792
      PMID: 38576525
    • Journal Article
      New opportunity for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation.
      Pitt B, Iyer SPN, Humes HD. Eur J Heart Fail, 2024 Mar; 26 (3): 534 - 536. DOI:10.1002/ejhf.3177
      PMID: 38390738
    • Proceeding / Abstract / Poster
      In Vivo Assessment of a Manual Single Lumen Alternating Micro-Batch Hemodiafiltration (mSLAMB) System.
      Lanker SL, Pino CJ, Humes HD, Chawla L, Johnston KA. Blood Purif, 2024 Mar 27; DOI:10.1159/000538358
      PMID: 38537620
    • Journal Article
      Rationale and Design of NEUTRALIZE-AKI: A Multicenter, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy.
      Yessayan L, Humes HD, Scribe EC, Iyer SPN, Chung KK. Nephron, 2024 148 (1): 43 - 53. DOI:10.1159/000531880
      PMID: 37442112
    • Journal Article
      An Immunoprotective Multi-Channel Kidney Bioreactor for Implantable Renal Replacement
      Torres A, Porock E, Blaha C, Wright N, Sorrentino T, Kim EJ, Chen C, Haniff TM, Chui BW, Moyer J, Brakeman PR, Humes HD, Fissell WH, Roy S. Journal of the American Society of Nephrology, 2023 Nov; 34 (11S): 727 - 727. DOI:10.1681/asn.20233411s1727c
    • Journal Article
      Hemolytic Uremic Syndrome-Induced Acute Kidney Injury Treated via Immunomodulation with the Selective Cytopheretic Device.
      Hambrick HR, Short K, Askenazi D, Krallman K, Pino C, Yessayan L, Westover A, Humes HD, Goldstein SL. Blood Purif, 2023 52 (9-10): 812 - 820. DOI:10.1159/000531963
      PMID: 37607519